Immutep Ltd
Immutep Ltd (IMM) is a biotechnology company focused on developing innovative immunotherapy treatments for cancer and autoimmune diseases. The company specializes in the discovery and development of LAG-3 (Lymphocyte Activation Gene-3) related products, which are designed to enhance the immune response against tumors and regulate immune activity in autoimmune disorders. Immutep operates primarily within the biopharmaceutical sector, leveraging its proprietary technologies to create therapies that aim to improve patient outcomes in oncology and beyond.